The Maudsley Prescribing Guidelines in Psychiatry 2021
DOI: 10.1002/9781119870203.mpg001
|View full text |Cite
|
Sign up to set email alerts
|

Schizophrenia and Related Psychoses

Abstract: Despite disagreements about nomenclature, patients who develop schizophrenic or schizophrenialike symptoms in later life are often seen in clinical practice. Questions about the etiology of late-life psychotic disorders and about their similarities or differences from early-onset disorders remain unanswered. Neuroimaging techniques have been used to study patients with late onset of psychosis, and in substantial subgroups of patients (from 25% to 100% in various studies) compared with agematched control subjec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 1,987 publications
(22 reference statements)
0
2
0
Order By: Relevance
“…A slower titration rate than suggested by guidelines (Taylor and Barnes, 2018) was chosen (Table 1). In addition, a close monitoring protocol was adopted, which included a three times daily measurement of temperature, blood pressure and heart rate.…”
Section: Case Descriptionmentioning
confidence: 99%
“…A slower titration rate than suggested by guidelines (Taylor and Barnes, 2018) was chosen (Table 1). In addition, a close monitoring protocol was adopted, which included a three times daily measurement of temperature, blood pressure and heart rate.…”
Section: Case Descriptionmentioning
confidence: 99%
“…Quetiapine is an atypical antipsychotic drug (a second-generation antipsychotic drug) used to treat schizophrenia, bipolar, borderline personality, and major depressive disorders; broadly speaking, this treatment has numerous neurocognitive, neuroprotective, and potential off-label indications [ 1 , 2 ]. Developed in 1985, the US approved quetiapine for medical use in 1997; now, it is on the World Health Organization’s List of Essential Medicines [ 3 , 4 ].…”
Section: Introductionmentioning
confidence: 99%